A longitudinal discriminant analysis is applied to build predictive models based on repeated measurements of serum hepatitis C virus RNA. These models are evaluated through the partial area under the receiver operating curve index (PA index) and, the final selection of the best model is based on cross-validated estimates of the PA index. Models are compared by building 95% bootstrap confidence interval for the difference in PA index between two models. Data from a randomised trial, in which chronic HCV patients were enrolled, are used to illustrate the application of the proposed method to predict treatment outcome.
Get full access to this article
View all access options for this article.
References
1.
Neumann AU, Lam NP, Dahari H. et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science1998; 282: 103-7.
2.
Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet2001; 358: 958-65.
3.
Fried MW, Shiffman ML, Reddy KRPeginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection . New England Journal of Medicine2002; 347: 975-82.
4.
Hadziyannis S., Sette HJ, Morgan T.Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Annals of Internal Medicine2004; 140: 346-55.
5.
Davis GL, Wong JB, McHutchinson JG, Manns MP, Harvey J., Albrecht J.Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C. Hepatology2003; 38: 645-52.
6.
Zeuzem S., Pawlotsky JM, Lukasiewicz E. et al.; DITTO-HCV Study Group. International, multicenter, randomized, controlled study comparing dynamically individualized versus standard teratment in patents with hepatitis C. Journal of Hepatology2005; 43: 250-7.
7.
Tomasko L., Helms RW, Snapinn SMA discriminant analysis extension to mixed models. Statistics in Medicine1999; 18: 1249-60.
8.
Dodd LE, Pepe MSPartial AUC estimation and regression. Biometrics2003; 59: 614-23.
9.
McClish DKAnalysing a portion of the ROC curve. Medical Decision Making1989; 9: 190-5.
10.
Jennrich RI , Schluchter MDUnbalanced repeated-measures models with structured covariance matrices. Biometrics1986; 4: 805-20.
11.
Laird NM, Ware JHRandom-effects models for longitudinal data. Biometrics1982; 38: 963-74.
Wernecke KD , Kalb G., Schink T., Wegner B.A mixed model approach to discriminant analysis with longitudinal data. Biometrical Journal2004; 2: 246-54.
14.
Youden WJIndex for rating diagnostic tests. Cancer1950; 3: 32-35.
15.
Schisterman EF, Faraggi D., Reiser B., Hu J.Youden index and the optimal threshold for markers with mass at zero. Statistics in Medicine2008; 27: 297-315.
16.
Metz CEBasic principles of ROC analysis. Seminars in Nuclear Medicine1978; 8: 283-98.
17.
Hanley JA, McNeil BJThe meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology1982; 143: 29-36.
18.
Metz CEROC methodology in radiologic imaging. Investigative radiology1986; 21: 720-33.
19.
Zweig MH, Campbell G.Receiver operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clinical Chemistry1993 ; 39: 561-77.
20.
Obuchowski NAReceiver operating characteristic curves and their use in Radiology. Radiology2003; 229: 3-8.
21.
Shapiro DEThe interpretation of diagnostic tests. Statistical Methods in Medical Research1999; 8: 113-34.
22.
Swets J., Pickett RMEvaluation of the diagnosic systems: methods from signal detection theory . Academic Press, New York ; 1982.
23.
Zhang DD, Zhou XH, Freeman Jr FH, Freeman JLK.A non parametric method for the comparison of partial areas under ROC curves and its application to large health care data sets. Statistics in Medicine2002; 21: 701-15.
24.
Charlson ME , Ales KL, Simon R., MacKenzie CRWhy predictive indexes perform less well in validation studies: is it magic or methods?Archives of Internal Medicine1987; 147: 2155-61.
25.
Steyerberg EW, Bleeker SE, Moll HA, Grobbee DE, Moons KGInternal and external validation of predictive models: a simulation study of bias and precision in small samples. Journal of Clinical Epidemiology2003; 56: 441-7.
26.
Efron B.The jackknife, the bootstrap and other resampling plans. SIAM, Philadelphia; 1982.
27.
Shao J., Tu D.The jackknife and bootstrap. Springer, New York; 1995.
28.
Davis GLMonitoring of viral levels during therapy of hepatitis C. Hepatology2002; 36(S1): S145-61.
29.
Kim TH, Kim KA, Lim YS et al. Prediction of treatment outcome in chronic hepatitis C patients based on viral dynamics during high-dose induction interferon and ribavirin therapy. Intervirology2005; 48: 230-8.
30.
Lee SL, Abdo AAPredicting antiviral treatment response in chronic hepatitis C: how accurate and how soon?Journal of Antimicrobial Chemotherapy2003; S1: 487-91.
31.
Bleeker SE, Moll HA, Steyerberg EW et al. External validation is necessary in prediction research: a clinical example. Journal of Clinical Epidemiology2003; 56: 826-32.
32.
Hanley JA, McNeil BJA method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology1983 ; 148: 839-43.
33.
DeLong ER, DeLong DM, Clarke-Pearson DLComparing the area under two or more correlated receiver operating characteristic curves: a non parametric approach. Biometrics1988; 44: 837-45.
